Table 1 Descriptive statistics
AstraZeneca | Comparison group | |
|---|---|---|
N | 99,883 | 186,387 |
Person-days | 1,356,733 | 2,520,648 |
Mean (SD) age | 42.3 (12.9) | 41.9 (12.9) |
Women, N (%) | 82,457 (82.6) | 156,602 (84) |
Norwegian born, N (%) | 82,631 (82.7) | 148,197 (79.5) |
Occupational groups | ||
Physicians, N (%) | 6226 (6.2) | 11,882 (6.4) |
Health professionals, N (%) | 33,522 (33.6) | 59,676 (32.0) |
Health associate professionals, N (%) | 6110 (6.1) | 9794 (5.3) |
Personal care workers, N (%) | 52,989 (53.1) | 102,995 (55.3) |
Cleaners, N (%) | 1036 (1.0) | 2040 (1.1) |
Daily health care use per 1000 HCWs | ||
Two weeks prior to March 11th | ||
All health care | 10.5 | 13.4 |
Primary care | 10.2 | 12.4 |
Inpatient specialist care | 0.3 | 1.2 |
First week after March 11th | ||
All health care | 19 | 13.7 |
Primary care | 18.5 | 12.5 |
Inpatient specialist care | 0.7 | 1.3 |
Second week after March 11th | ||
All health care | 18.5 | 12.9 |
Primary care | 17.9 | 12 |
Inpatient specialist care | 0.9 | 1.0 |